---
figid: PMC3410405__zlj9991024570001
figtitle: Pathophysiology of (A) mammalian target of rapamycin (mTOR) inhibitor–induced
  hyperlipidemia and (B) phosphoinositide 3- kinase–Akt–mTOR pathway inhibitor–induced
  hyperglycemia
organisms:
- NA
organisms_ner:
- Drosophila melanogaster
pmcid: PMC3410405
filename: zlj9991024570001.jpg
figlink: /pmc/articles/PMC3410405/figure/F1/
number: F1
caption: Pathophysiology of (A) mammalian target of rapamycin (mTOR) inhibitor–induced
  hyperlipidemia and (B) phosphoinositide 3- kinase–Akt–mTOR pathway inhibitor–induced
  hyperglycemia. LPL, lipoprotein lipase; TG, triglyceride; VDL, very low density
  lipoprotein.
papertitle: Management of Metabolic Effects Associated With Anticancer Agents Targeting
  the PI3K-Akt-mTOR Pathway.
reftext: Naifa L. Busaidy, et al. J Clin Oncol. 2012 Aug 10;30(23):2919-2928.
year: '2012'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.7028804
figid_alias: PMC3410405__F1
figtype: Figure
redirect_from: /figures/PMC3410405__F1
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC3410405__zlj9991024570001.html
  '@type': Dataset
  description: Pathophysiology of (A) mammalian target of rapamycin (mTOR) inhibitor–induced
    hyperlipidemia and (B) phosphoinositide 3- kinase–Akt–mTOR pathway inhibitor–induced
    hyperglycemia. LPL, lipoprotein lipase; TG, triglyceride; VDL, very low density
    lipoprotein.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - CkIIbeta
  - Andorra
  - Anp
  - Acam
  - Tg
  - mas
  - myoblast-specific
  - beta-Spec
  - betaTub56D
  - betaTry
  - anon-70Da
  - glucose
---
